Operating Income Summary of Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited's latest annual operating income in 2023 was 5.78 Billion CNY , down -18.7% from previous year.
Sino Biopharmaceutical Limited's latest quarterly operating income in 2024 Q1 was 1.8 Billion CNY , down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported an annual operating income of 6.69 Billion CNY in 2022, down -64.53% from previous year.
Sino Biopharmaceutical Limited reported an annual operating income of 18.86 Billion CNY in 2021, up 285.82% from previous year.
Sino Biopharmaceutical Limited reported a quarterly operating income of 1.8 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Sino Biopharmaceutical Limited reported a quarterly operating income of 1.56 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Operating Income of Sino Biopharmaceutical Limited (2023 - 1999)

Year	Operating Income	Operating Income Growth
2023	5.78 Billion CNY	-18.7%
2022	6.69 Billion CNY	-64.53%
2021	18.86 Billion CNY	285.82%
2020	4.88 Billion CNY	-15.84%
2019	5.8 Billion CNY	16.79%
2018	4.97 Billion CNY	19.14%
2017	4.17 Billion CNY	-11.45%
2016	4.71 Billion CNY	76.02%
2015	2.67 Billion CNY	33.57%
2014	2 Billion CNY	-8.66%
2013	2.19 Billion CNY	51.73%
2012	1.44 Billion CNY	77.52%
2011	815.03 Million CNY	-12.64%
2010	932.96 Million CNY	32.24%
2009	705.52 Million CNY	31.49%
2008	536.57 Million CNY	43.76%
2007	373.23 Million CNY	56.51%
2006	238.47 Million CNY	49.78%
2005	159.21 Million CNY	-43.78%
2004	283.21 Million CNY	58.61%
2003	178.56 Million CNY	23.07%
2002	145.08 Million CNY	14.34%
2001	126.88 Million CNY	35.71%
2000	93.49 Million CNY	-0.32%
1999	93.79 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	1.8 Billion CNY	0.0%
2024 Q2	1.8 Billion CNY	0.0%
2023 Q2	1.56 Billion CNY	0.0%
2023 Q1	1.56 Billion CNY	80.71%
2023 Q3	- HKD	-100.0%
2023 FY	5.43 Billion CNY	-18.7%
2022 Q3	1.35 Billion CNY	-13.99%
2022 Q2	1.58 Billion CNY	0.0%
2022 Q1	1.58 Billion CNY	96.2%
2022 FY	6.69 Billion CNY	-64.53%
2022 Q4	864.75 Million CNY	-36.4%
2021 Q2	1.77 Billion CNY	43.18%
2021 Q3	805.67 Million CNY	-54.71%
2021 Q4	805.67 Million CNY	0.0%
2021 FY	18.86 Billion CNY	285.82%
2021 Q1	1.24 Billion CNY	35.87%
2020 Q4	914.5 Million CNY	-26.74%
2020 Q2	1.53 Billion CNY	28.08%
2020 FY	4.88 Billion CNY	-15.84%
2020 Q1	1.19 Billion CNY	-2.17%
2020 Q3	1.24 Billion CNY	-18.45%
2019 Q4	1.22 Billion CNY	-35.15%
2019 FY	5.8 Billion CNY	16.79%
2019 Q1	1.25 Billion CNY	90.19%
2019 Q3	1.88 Billion CNY	29.66%
2019 Q2	1.45 Billion CNY	16.17%
2018 Q4	657.48 Million CNY	-66.48%
2018 FY	4.97 Billion CNY	19.14%
2018 Q1	1.03 Billion CNY	-18.09%
2018 Q2	1.31 Billion CNY	27.41%
2018 Q3	1.96 Billion CNY	48.68%
2017 Q4	1.26 Billion CNY	-1.71%
2017 Q3	1.28 Billion CNY	-3.61%
2017 Q2	1.33 Billion CNY	-3.33%
2017 FY	4.17 Billion CNY	-11.45%
2017 Q1	1.38 Billion CNY	20.25%
2016 Q4	1.14 Billion CNY	-16.29%
2016 Q1	521.9 Million CNY	-32.03%
2016 FY	4.71 Billion CNY	76.02%
2016 Q2	1.67 Billion CNY	220.72%
2016 Q3	1.37 Billion CNY	-18.09%
2015 Q4	767.8 Million CNY	-16.88%
2015 Q1	436.96 Million CNY	-18.72%
2015 Q3	923.69 Million CNY	67.99%
2015 FY	2.67 Billion CNY	33.57%
2015 Q2	549.84 Million CNY	25.83%
2014 Q1	360.71 Million CNY	-68.79%
2014 Q4	537.62 Million CNY	-27.96%
2014 Q3	746.25 Million CNY	77.46%
2014 Q2	420.52 Million CNY	16.58%
2014 FY	2 Billion CNY	-8.66%
2013 Q4	1.15 Billion CNY	142.74%
2013 FY	2.19 Billion CNY	51.73%
2013 Q1	283.62 Million CNY	-29.8%
2013 Q2	279.78 Million CNY	-1.35%
2013 Q3	476.1 Million CNY	70.17%
2012 FY	1.44 Billion CNY	77.52%
2012 Q4	404.03 Million CNY	136.24%
2012 Q3	171.02 Million CNY	-72.84%
2012 Q1	241.99 Million CNY	-5.22%
2012 Q2	629.77 Million CNY	160.25%
2011 Q1	192.44 Million CNY	0.0%
2011 Q2	188.09 Million CNY	-2.26%
2011 Q3	182.18 Million CNY	-3.14%
2011 Q4	255.32 Million CNY	40.15%
2011 FY	815.03 Million CNY	-12.64%
2010 Q1	172.02 Million CNY	0.0%
2010 Q2	175.37 Million CNY	1.95%
2010 FY	932.96 Million CNY	32.24%
2009 FY	705.52 Million CNY	31.49%
2008 FY	536.57 Million CNY	43.76%
2007 FY	373.23 Million CNY	56.51%
2006 FY	238.47 Million CNY	49.78%
2005 FY	159.21 Million CNY	-43.78%
2004 FY	283.21 Million CNY	58.61%
2003 FY	178.56 Million CNY	23.07%
2002 FY	145.08 Million CNY	14.34%
2001 FY	126.88 Million CNY	35.71%
2000 FY	93.49 Million CNY	-0.32%
1999 FY	93.79 Million CNY	0.0%

Peer Operating Income Comparison of Sino Biopharmaceutical Limited

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	-8437.531%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	-544.323%

Global Stocks Search

Sino Biopharmaceutical Limited (1177.HK)

Operating Income Summary of Sino Biopharmaceutical Limited

Annual Operating Income Chart of Sino Biopharmaceutical Limited (2023 - 1999)

Historical Annual Operating Income of Sino Biopharmaceutical Limited (2023 - 1999)

Peer Operating Income Comparison of Sino Biopharmaceutical Limited